- Home
- PFO vs CSBR Comparison
PFO vs CSBR Comparison
Compare PFO & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFO
- CSBR
- Stock Information
- Founded
- PFO 1991
- CSBR 1985
- Country
- PFO United States
- CSBR United States
- Employees
- PFO N/A
- CSBR N/A
- Industry
- PFO Finance Companies
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PFO Finance
- CSBR Health Care
- Exchange
- PFO Nasdaq
- CSBR Nasdaq
- Market Cap
- PFO 116.6M
- CSBR 113.0M
- IPO Year
- PFO N/A
- CSBR 1986
- Fundamental
- Price
- PFO $9.14
- CSBR $8.24
- Analyst Decision
- PFO
- CSBR Strong Buy
- Analyst Count
- PFO 0
- CSBR 1
- Target Price
- PFO N/A
- CSBR $12.00
- AVG Volume (30 Days)
- PFO 31.8K
- CSBR 38.4K
- Earning Date
- PFO 01-01-0001
- CSBR 07-17-2025
- Dividend Yield
- PFO 6.51%
- CSBR N/A
- EPS Growth
- PFO N/A
- CSBR N/A
- EPS
- PFO N/A
- CSBR 0.46
- Revenue
- PFO N/A
- CSBR $58,591,000.00
- Revenue This Year
- PFO N/A
- CSBR $15.11
- Revenue Next Year
- PFO N/A
- CSBR $7.80
- P/E Ratio
- PFO N/A
- CSBR $17.82
- Revenue Growth
- PFO N/A
- CSBR 19.03
- 52 Week Low
- PFO $6.90
- CSBR $3.60
- 52 Week High
- PFO $8.51
- CSBR $11.99
- Technical
- Relative Strength Index (RSI)
- PFO 59.24
- CSBR 69.99
- Support Level
- PFO $9.03
- CSBR $6.27
- Resistance Level
- PFO $9.17
- CSBR $8.58
- Average True Range (ATR)
- PFO 0.14
- CSBR 0.64
- MACD
- PFO 0.00
- CSBR 0.28
- Stochastic Oscillator
- PFO 95.69
- CSBR 96.63
About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated
Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end management investment company. Its primary investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.